Melanocortin signaling and anorexia in chronic disease states.

Abstract

Data from both rodent models and humans suggest that intact neuronal melanocortin signaling is essential to prevent obesity, as mutations that decrease the melanocortin signal within the brain induce hyperphagia and excess body fat accumulation. Melanocortins are also involved in the pathogenesis of disorders at the opposite end of the spectrum of energy homeostasis, the anorexia and weight loss associated with inflammatory and neoplastic disease processes. Studies using melanocortin antagonists (SHU9119 or agouti-related peptide) or genetic approaches (melanocortin-4 receptor null mice) suggest that intact melanocortin tone is required for anorexia and weight loss induced by injected lipopolysaccharide (an inflammatory gram-negative bacterial cell wall product) or by implantation of prostate or lung cancer cells. Although the precise mechanism whereby peripheral inflammatory/neoplastic factors activate the melanocortin system remains unknown, the proinflammatory cytokines (interleukin-1, interleukin-6, and tumor necrosis factor-alpha) that are produced in the hypothalamus of rodents during both inflammatory and neoplastic disease processes likely play a role. The data presented in this paper summarize findings that implicate neuronal melanocortin signaling in inflammatory anorexia.

• Authors: Brent E Wisse, Michael W Schwartz, David E Cummings
• Journal: Annals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 994 Pg. 275-81 (Jun 2003) ISSN: 0077-8923 [Print] United States
• PMID: 12851326 (Publication Type: Journal Article, Review)

Chemical References

• Receptors, Corticotropin
• Receptors, Melanocortin
• alpha-MSH
• Pro-Opiomelanocortin

Topics

• Animals
• Anorexia (metabolism)
• Arcuate Nucleus of Hypothalamus (metabolism)
• Cachexia (metabolism)
• Humans
• Obesity (metabolism)
• Pro-Opiomelanocortin (genetics, metabolism)
• Receptors, Corticotropin (metabolism)
• Receptors, Melanocortin
• Signal Transduction (physiology)
• alpha-MSH (antagonists & inhibitors, metabolism)